F3 and COVID-19: Markers of coagulation activation (D-dimer, thrombin-antithrombin complexes (TATc) and soluble tissue factor) (9, 10) were strongly elevated in BALF of COVID-19 patients relative to levels measured in BALF from control subjects (Figure 1).